Dosidal · Switzerland

Xultophy, Injektionslösung

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:65041 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 65041
atc: A10AE56
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2014-09-12
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: A10AE56
authorisation_number: 65041
form: LSPA
holder: Novo Nordisk Pharma AG
holder_partner_nr: 1000306
it_number: 07.06.
name: Xultophy, Injektionslösung
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
h9CHKxwq3sZ9kjqRR9wCNCMVj2NuS6K_5rsOYDz_3Y0r7rz208NR-65IDVWkyoSas0XLZBH7JgusyIeyxAJziw
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:65041 · Related records in other markets · Dosidal